Literature DB >> 11684603

Providing hepatitis B vaccination to injection drug users: referral to health clinics vs on-site vaccination at a syringe exchange program.

D C Des Jarlais1, D G Fisher, J C Newman, B N Trubatch, M Yancovitz, D Paone, D Perlman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11684603      PMCID: PMC1446878          DOI: 10.2105/ajph.91.11.1791

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


× No keyword cloud information.
  4 in total

1.  Vaccination strategies for targeted and difficult-to-access groups.

Authors:  B N Trubatch; D G Fisher; H H Cagle; A M Fenaughty
Journal:  Am J Public Health       Date:  2000-03       Impact factor: 9.308

2.  High compliance with a hepatitis B virus vaccination program among intravenous drug users.

Authors:  P Mezzelani; L Venturini; G Turrina; F Lugoboni; D C Des Jarlais
Journal:  J Infect Dis       Date:  1991-04       Impact factor: 5.226

3.  Tuberculosis screening at a syringe exchange program.

Authors:  D C Perlman; M P Perkins; N Solomon; L Kochems; D C Des Jarlais; D Paone
Journal:  Am J Public Health       Date:  1997-05       Impact factor: 9.308

4.  Provision of influenza and pneumococcal vaccines to injection drug users at a syringe exchange.

Authors:  S Stancliff; N Salomon; D C Perlman; P C Russell
Journal:  J Subst Abuse Treat       Date:  2000-04
  4 in total
  26 in total

1.  Hepatitis B vaccination among research participants, Seattle, Washington.

Authors:  Holly Hagan; Hanne Thiede; James P McGough; E Russell Alexander
Journal:  Am J Public Health       Date:  2002-11       Impact factor: 9.308

2.  Hepatitis B virus immunization among young injection drug users in San Francisco, Calif: the UFO Study.

Authors:  Paula J Lum; Kristen C Ochoa; Judith A Hahn; Kimberly Page Shafer; Jennifer L Evans; Andrew R Moss
Journal:  Am J Public Health       Date:  2003-06       Impact factor: 9.308

3.  Advancing integration of HIV, STD, and viral hepatitis services: state perspectives.

Authors:  Peter Whiticar; Thomas Liberti
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

4.  Integrating viral hepatitis prevention into public health programs serving people at high risk for infection: good public health.

Authors:  Joanna Buffington; T Stephen Jones
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

5.  Adherence to hepatitis B virus vaccination at syringe exchange sites.

Authors:  Frederick L Altice; Robert D Bruce; Mary R Walton; Marta I Buitrago
Journal:  J Urban Health       Date:  2005-03-03       Impact factor: 3.671

6.  Unmet health care needs and hepatitis C infection among persons who inject drugs in Denver and Seattle, 2009.

Authors:  Alia A Al-Tayyib; Hanne Thiede; Richard D Burt; Stephen Koester
Journal:  Prev Sci       Date:  2015-02

7.  Cost-effectiveness analysis of behavioral interventions to improve vaccination compliance in homeless adults.

Authors:  Barbara Greengold; Adeline Nyamathi; Gerald Kominski; Dorothy Wiley; Mary Ann Lewis; Felicia Hodge; Mendel Singer; Brennan Spiegel
Journal:  Vaccine       Date:  2008-11-27       Impact factor: 3.641

Review 8.  Bloodborne viral hepatitis infections among drug users: the role of vaccination.

Authors:  Fabio Lugoboni; Gianluca Quaglio; Paolo Civitelli; Paolo Mezzelani
Journal:  Int J Environ Res Public Health       Date:  2009-01-22       Impact factor: 3.390

9.  HIV/hepatitis prevention in drug abuse treatment programs: guidance from research.

Authors:  James L Sorensen; Carmen L Masson; David C Perlman
Journal:  Sci Pract Perspect       Date:  2002-07

10.  Hepatitis vaccination of men who have sex with men at gay pride events.

Authors:  Erik David Storholm; Dennis G Fisher; Grace L Reynolds; Lucy E Napper; Timothy A Morrisse; Lee M Kochems
Journal:  Prev Sci       Date:  2010-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.